Belite Bio, Inc (NASDAQ: BLTE) ('Belite Bio” or the 'Company”), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have ...
One institutional investor just doubled down on this beaten-up homebuilder supplier—here’s why the timing matters.
Cantor disclosed its first position in a newly listed Solana ETF, adding momentum to TradFi's shift toward regulated crypto ...
NEW YORK, NY / ACCESS Newswire / December 1, 2025 / Some companies advance with steady progress. Others advance through pivotal moments that redefine what they can build. SMX (NASDAQ:SMX) spent years ...
NEW YORK CITY, NY / ACCESS Newswire / December 1, 2025 / Every company has a year that separates “before” from “after.” A year that doesn’t just add progress to a timeline but redraws the entire arc.
NEW YORK, NY / ACCESS Newswire / December 1, 2025 / Trust is the most valuable commodity in the modern economy, yet it’s the ...
NEW YORK CITY, NEW YORK / ACCESS Newswire / December 1, 2025 / Global trade depends on the assumption that everyone follows ...
Billing and shipments at Fort Smith-based ArcBest posted small gains in November, but the shipping and logistics company said ...
Robot negotiations with another potential acquirer fell through, and its main creditor has set a deadline of Jan. 15 for ...
The Republican-led U.S. House Committee on Financial Services just published a 53-page report accusing Biden Administration ...
Sable Offshore has requested that federal regulators assume authority over its attempts to restart oil production in ...
Construction services heavyweight Cardinal Infrastructure Group Inc. surged into the public markets Monday, unveiling a $242 million initial public offering that pushed the fast-growing firm onto the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback